TrendingWallStreet.com Releases Alerts on BLDP, MINE, EGY, and GERN

Whether it’s a bull or bear market, TrendingWallStreet has you covered. Take a few minutes to register with us at http://www.trendingwallstreet.com/ to get exclusive access to our free stock reports.

Ballard Power Systems Inc. (NASDAQ: BLDP) shares closed up 18.88 percent on Friday with nearly 14 million shares traded. The stock had one of the biggest volume advances on the NASDAQ. Last week the company announced the signing of a non-binding Memorandum of Understanding, or MOU, with Van Hool NV, Europe's fourth largest bus manufacturer, in support of the manufacture and further deployment of zero emission fuel cell buses. By February 2014 the companies plan to jointly respond to last week's call for proposals under the EU Hydrogen Fuel Cell Joint Undertaking, and also plan to jointly respond to other future calls for proposals under the Horizon 2020 program.

Get more information on Ballard Power Systems Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/BLDP

Minerco Resources, Inc. (OTC: MINE) shares closed down 32.14 percent this past Friday making it one of the biggest percentage losers in the OTC market. The stock traded about 140 million shares. The Company released its most recent product updates for all of its brands: LEVEL 5™, COFFEE BOOST™ and VitaminFIZZ®.

Get more information on Minerco Resources, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/MINE

Vaalco Energy Inc. (NYSE: EGY) shares closed up 9.32 percent on Friday with nearly 2 million shares traded. The stock was one of the biggest percentage climbers in the NYSE. The gains came after Angolan authorities cleared the oil and gas exploration company and partner Sonangol to start drilling off the African nation's coast.

Get more information on Vaalco Energy Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/EGY

Geron Corporation (NASDAQ: GERN) shares closed down a modest 0.17 percent on Friday with about 22.5 million shares traded. The stock jumped as much as 18% before retracing on Friday. The move came after an encouraging study by the Mayo Clinic demonstrated the effectiveness of Geron's experimental myelofibrosis drug, imetelstat.

Get more information on Geron Corporation and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/GERN

Disclosure: TrendingWallStreet.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.